🔗 Share this article

The prestigious award in medical science was granted for transformative discoveries that illuminate how the immune system attacks harmful infections while protecting the body's own cells.

A trio of renowned researchers—from Japan Prof. Sakaguchi and American experts Mary Brunkow and Fred Ramsdell—share this honor.

The research identified unique "sentinels" within the defense system that remove malfunctioning immune cells that could harming the organism.

These findings are now enabling new treatments for autoimmune diseases and cancer.

These laureates will divide a monetary award valued at 11m SEK.

Crucial Discoveries

"Their work has been decisive for comprehending how the immune system operates and the reason we do not all suffer from serious self-attack conditions," stated the head of the award panel.

The trio's studies address a fundamental mystery: In what way does the immune system protect us from numerous invaders while leaving our own tissues unharmed?

Our body's protection system employs white blood cells that scan for signs of infection, even pathogens and germs it has not met before.

These defenders employ sensors—called recognition units—that are produced by chance in countless combinations.

That provides the defense network the capacity to fight a broad range of threats, but the randomness of the process unavoidably creates white blood cells that may target the host.

Security Guards of the Body

Researchers previously understood that some of these harmful defense cells were eliminated in the immune organ—the site where immune cells develop.

The latest Nobel Prize recognizes the identification of T-reg cells—described as the body's "peacekeepers"—which patrol the body to neutralize any immune cells that assault the healthy cells.

It is known that this mechanism malfunctions in self-attack conditions such as type-1 diabetes, multiple sclerosis, and RA.

The Nobel panel stated, "These findings have established a novel area of investigation and accelerated the development of new treatments, for instance for cancer and autoimmune diseases."

In malignancies, regulatory T-cells prevent the system from fighting the tumor, so studies are aimed at lowering their quantity.

In autoimmune diseases, experiments are exploring boosting T-reg cells so the body is no longer under attack. A similar method could also be useful in minimizing the chances of transplanted organ failure.

Innovative Studies

Prof Sakaguchi, of a Japanese institution, performed experiments on mice that had their immune gland removed, leading to self-attack conditions.

The researcher demonstrated that introducing immune cells from healthy animals could prevent the illness—implying there was a mechanism for preventing defenders from harming the host.

Mary Brunkow, from the a research center in a US city, and Fred Ramsdell, currently at Sonoma Biotherapeutics in a California city, were investigating an inherited autoimmune disease in rodents and people that led to the discovery of a genetic factor vital for how T-regs operate.

"Their groundbreaking work has uncovered how the body's defenses is controlled by T-reg cells, stopping it from mistakenly targeting the healthy cells," said a leading biological science specialist.

"The work is a striking illustration of how basic physiological research can have broad consequences for human health."